Content area

Abstract

Indaptus Therapeutics Inc (INDP) - Medical Equipment - Deals and Alliances Profile

Indaptus Therapeutics Inc (Indaptus) is a biotechnology company that focuses on developing innovative therapies that harness the body's immune system to treat cancer and infectious diseases. Its activities carry out creating proprietary, attenuated, and killed non-pathogenic gram-negative bacteria designed to activate both innate and adaptive immune responses. Indaptus' pipeline products include INDP010, INDP020, INDP012, INDP014, and INDP016. The company's products are aimed at healthcare providers and researchers working in oncology and infectious disease treatment. Indaptus is headquartered in New York, the US

Indaptus Therapeutics Inc (INDP) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

Details

1007133
Company / organization
Title
Indaptus Therapeutics Inc (INDP)
Publication title
Number of pages
34
Publication year
2025
Publication date
2025
Publisher
GlobalData plc
Place of publication
London
Country of publication
United Kingdom
Publication subject
Source type
Report
Language of publication
English
Document type
Company Report
Document feature
Mergers & acquisitions
ProQuest document ID
2575750678
Document URL
https://www.proquest.com/reports/indaptus-therapeutics-inc-indp/docview/2575750678/se-2?accountid=208611
Copyright
Copyright GlobalData plc 2025
Last updated
2025-11-20
Database
ProQuest One Academic